Chief Executive, Asahi Kasei Therapeutics (U.S. and Europe)
Appears in 1 story
Leading commercial rollout of Hovilpri
The Food and Drug Administration approved Hovilpri (pritelivir) on October 9 for persistent herpes sores in adults with weakened immune systems. It is the first herpes treatment with a new mechanism of action in nearly 30 years.
Updated 1 hour ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
